Navigation Links
Thrombosis Guidelines Emphasize Difficult Choices for Pregnant Women
Date:6/24/2008

New Recommendations Address Presurgery and Pediatric Dilemmas

NORTHBROOK, Ill., June 24 /PRNewswire/ -- New evidence-based guidelines address the prevention and management of thrombosis in key patient populations and reinforce recommendations related to the routine use of preventive therapies. Published as a supplement in the June issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), Antithrombotic and Thrombolytic Therapy: ACCP Evidence-Based Clinical Practice Guidelines, Eighth Edition was developed by an international panel of 90 experts and includes more than 700 of the most comprehensive recommendations related to the prevention, treatment, and long-term management of thrombotic disorders. The guidelines include chapters on the challenges in preventing and treating thrombosis in pregnant women and children, and on managing peri- and postoperative patients, while also reinforcing previous guidelines related to the routine use of preventive therapies, including aspirin.

"For years, clinicians have faced challenges in preventing and managing thrombosis in women who are pregnant or patients who require surgery," said guidelines panel chair Jack Hirsh, MD, FCCP, Henderson Research Center, Hamilton, ON, Canada. "The new guidelines address many troublesome issues in antithrombotic therapy and provide clinicians with a variety of options for care in special patient groups." Antithrombotic and thrombolytic therapies are used to prevent and treat thrombosis or blood clotting that arises in arteries, veins, and the heart.

Pregnant Women

The new ACCP guidelines address challenging issues facing women who are pregnant or wish to become pregnant while undergoing long-term antithrombotic therapy. Pregnant women taking vitamin K antagonists (VKA), such as the anticoagulant warfarin, have an increased risk for birth defects and miscarriage and are, therefore, advised to stop taking VKAs before 6 weeks
'/>"/>

SOURCE American College of Chest Physicians
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
2. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
3. New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry
4. Trellis(R) Catheter Removes Blood Clots Quickly, Restoring Blood Flow in 771 Deep Vein Thrombosis (DVT) Patients
5. Study Finds Repeated Episodes of Stent Thrombosis Common
6. Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI)
7. DHHS Guidelines Support Use of Trofile(TM) Assay Prior to CCR5 Inhibitor Use
8. New Guidelines: Antibiotic Prophylaxis
9. ACR Supports American Cancer Society Inclusion of CT Colonography (Virtual Colonoscopy) as Recommended Screening Tool for Colorectal Cancer in New Screening Guidelines
10. Lung Cancer Alliance Commends NCCN on Screening Guidelines
11. Published Guidelines Further Support Use of Bioimpedance Measurement Technology for Early Assessment of Lymphedema

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., , RANCHO CORDOVA, Calif., Nov. 25 /PRNew...iary of American Pacific Corporation (Nasdaq: APF...ntal Responsibility and Sustainability Award at th... by the California Manufacturers and Technology As...ociation (IEA) and the Chemical Industry Council o...
(Date:11/25/2009)..., , HARBIN, China, Nov. 25 /PRNew...c. ("China Sky One Medical" or "the Company") (Nas...tical company developing and producing,over-the-co...C"), today,announced that the Company recently pas... of Pharmaceutical and Biological Products ("ICPBP...
(Date:11/25/2009)..., , NEW YORK, Nov. 25 /PRNewswire/ -...earch report is available in its catalogue: ,, ...ive ,, http://www.reportlinker.com/p0164330/...e.html ,, Rising incidence of breast cancer in... principal factor influencing growth in the mammog...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8Death at Assisted Living Facility Points to Desperate Need for Better Regulations from the State 49692 1Death at Assisted Living Facility Points to Desperate Need for Better Regulations from the State 49692 2Death at Assisted Living Facility Points to Desperate Need for Better Regulations from the State 49692 3Providence Tarzana Surgeon First in U S to Use New State of the Art Imaging Tool 49688 1Providence Tarzana Surgeon First in U S to Use New State of the Art Imaging Tool 49688 2Drinking Milk in the Morning May Help Stave off Lunchtime Hunger 49683 1Drinking Milk in the Morning May Help Stave off Lunchtime Hunger 49683 2
...2007 American Society of Clinical Oncology (ASCO) ...tients with AML and in,Refractory , ALL Patients P...teraction of Aloxi(R),with , the 5-HT3 Receptor Re...oblastoma Patients,Treated , with Multimodal Thera...Analysis of Irofulven in Second-Line HRPC,Patients...
... -- The Barbara,Ann Karmanos Cancer Institute,s Ph... medicine and oncology, presented the outcome,of o...ncer clinical,trials in North America and chaired ...c cancer therapies at the American Society of,Clin.... , The clinical trial, A Phase III Randomized Ope...
Other Medicine Technology:MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 10Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed 2Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed 3
(Date:11/30/2009)... CLEVELAND, Ohio, November 30 Si...oper of medical simulation systems, in collaborati...ROcedure Rehearsal Studio(TM),workshop for the fir...,Germany. , The Simbionix PROcedure Rehea...ator to enable clinicians to create practice scena...
(Date:11/30/2009)...le-aged men and women who engage in high levels of...ge to their knees and increasing their risk for os... at the annual meeting of the Radiological Society...at people with higher physical activity levels may...ies and, thus, at higher risk for developing osteo...
(Date:11/30/2009)...rge proportion of patients who undergo abdominal/p... and unnecessary additional image acquisition resu...ording to a study presented today at the annual me... (RSNA). , "It is the responsibility of all phys...that the dosage is as low as reasonably achievable...
(Date:11/30/2009).... 30, 2009 UT Southwestern Medical Center researc...lies stave off complications associated with asthm...ber issue of Pediatrics, suggest that interventi...ldren who have received specialized topical traini...s, emergency room visits and missed adult workdays...
(Date:11/29/2009)... Moravia,s Nanjing-based Service Deliver...ce , Brno, Czech Republic...tion solution provider, is pleased to announce its... 2009, to be held in Nanjing, China, on November 3...Union-based companies that have established and gr...
Breaking Medicine News(10 mins):Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 3Health News:Too much physical activity may lead to arthritis 2Health News:Unindicated CT series result in unnecessary radiation exposure for patients 2Health News:Unindicated CT series result in unnecessary radiation exposure for patients 3Health News:Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find 2Health News:Moravia Worldwide to Participate in the 5th EU-China Business Summit 2009 in Nanjing China 2
... Sixteen QHR hospital clients received unexpe...ry. The payments - ranging from $65,000 to more t...articipating in a unique and innovative partnershi...ps that experience less than projected risk manage...
...family has a correlate relationship with the invas...sted that, unlike E-cadherin, N-cadherin may promo...plore clinical pathological significance of E-cadh...sion of E-cadherin and N-cadherin in 62 cases of n...
...edes are under treatment with the blood-thinning d... Waran, which makes the initiation of treatment a ...ting. Now researchers at Uppsala University have ...of Medicine . , Some 20 research teams in four r...
.... 19 The PepsiCo Foundation today announced a thr...help ensure the survival and well-being of childre...ther are home to 40 percent of the world,s malnour...dren will work towards decreasing newborn and chil...
... Cardium Therapeutics (NYSE Alternext US: CXM) rep...bmitted on January 23, 2009 has been accepted by t...ock Exchange). , , (Logo: http://www.newscom....hange indicating that the company was considered t...
...stry Veteran Will Lead Company in Development of ,...l Food Ingredients , , ORLANDO, Fla., Feb. 19 Va...ck as President & Chief Executive Officer of t...(India) Ltd, Chennai, India) announced last Novemb...
Other Medicine News:Health News:QHR, Gallagher Partnership Yields More Thank $4 Million for QHR Hospital Clients 2Health News:Knowledge of genetics improves uncertain medication 2Health News:PepsiCo Foundation Announces Grant to Save the Children to Address Malnutrition in Developing Nations 2Health News:PepsiCo Foundation Announces Grant to Save the Children to Address Malnutrition in Developing Nations 3Health News:Cardium's Exchange Listing Compliance Plan Accepted by NYSE Alternext US 2Health News:Cardium's Exchange Listing Compliance Plan Accepted by NYSE Alternext US 3Health News:Cardium's Exchange Listing Compliance Plan Accepted by NYSE Alternext US 4Health News:Cardium's Exchange Listing Compliance Plan Accepted by NYSE Alternext US 5Health News:Valensa International's Dr. Rudi E. Moerck Appointed CEO 2
Pachycam
...ologies - plus wavefront analysis - in one easy-to...a single device, you can obtain refraction, cornea...vefront analysis. The 3-D Wave allows you to evalu...ve and cataract surgery screenings, evaluate posto...
...re sensor and continues to lead the way. PressureW...measures pressure, temperature and flow. With sign..., it also serves as your primary guidewire, as wel...gh-performance guidewire. , Intracoronary pressu...
...nd and MRI-guided vacuum assisted breast biopsies ...d, FDA-cleared ATEC system for a faster, safer, ea... biopsy. Its compassionate care at its best for th...eful for biopsy and diagnostic excision of breast ...
Medicine Products: